The global congenital hyperinsulinism treatment market is set to reach USD 100 million by 2023 and is expected to grow at a ...
The global Andersen Tawil syndrome treatment market is expected to surpass an impressive valuation of USD 1.9 Billion in 2023 ...
In 2023, the market is anticipated to be valued at USD 26.64 Billion, marking a significant starting point for a decade-long ...
The Industry is on the brink of a substantial surge, with the market size expected to reach USD 100 Million in 2023 and ...
Rheumatic heart disease is a serious complication resulting from rheumatic fever, which primarily affects children and young ...
The global Oncolytic Virus Cancer Therapy (OVT) market is expected to be valued at USD 22.86 million in 2023, with ...
Familial hypercholesterolemia (FH) is a genetic disorder characterized by high levels of low-density lipoprotein (LDL) ...